e-learning
resources
Glasgow 2004
Wednesday 08.09.2004
New developments in endobronchial treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Photodynamic therapy (PDT) in lung cancer with disease limited to endobronchial lesions
K. Moghissi, K. Dixon, A. C. Thorpe, C. Oxtoby (Goole, United Kingdom)
Source:
Annual Congress 2004 - New developments in endobronchial treatment
Session:
New developments in endobronchial treatment
Session type:
Oral Presentation
Number:
4292
Disease area:
Thoracic oncology
Abstract
Objective: to investigate the efficacy and long term results of PDT in a subset of patients with lung cancer with disease limited to bronchial wall and lumen.
Material & Methods: 16 patients amongst 207 undergoing bronchoscopic PDT for lung cancer. All patients had standard investigation, work up and staging procedure as well as assessment of bronchoscopic extent of the endoluminal lesion. PDT method was intravenous injection of 2mg/kg/bw of Photofrin followed 24-72 hours later by bronchoscopic illumination for 150-200 joules/cm. Results were assessed by review and bronchoscopy at 5-6 weeks post PDT and at regular intervals in follow up clinic until death.
Results:16 subjects (10 male 6 female) aged 53-74 (mean 65.2) received 26 treatments. 7 patients had previous treatment (including 3 resections) with curative intent. In these PDT was given for local recurrence. There was no operative mortality. 1 patient developed mild skin photosensitivity. Every patient had a period of complete response 6-24 months. 7 patients have died. Their survival was from 2-103 months (mean 55.9). 9 are alive from 6-36 months (mean 21.6). Mean & median survival for the whole group was 64 ± 10 m & 77 ± 9 m respectively.
Conclusion: Bronchoscopic PDT appears to be an effective therapeutic method in patients with cancer limited to endobronchial lesions. In this subset long survival can be expected provided there is no extra bronchial dissemination.
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Moghissi, K. Dixon, A. C. Thorpe, C. Oxtoby (Goole, United Kingdom). Photodynamic therapy (PDT) in lung cancer with disease limited to endobronchial lesions. Eur Respir J 2004; 24: Suppl. 48, 4292
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Effectiveness of photodynamic therapy (PDT) in lung cancer treatment
Source: Annual Congress 2009 - Treatment of lung cancer
Year: 2009
Place of cryotherapy, brachytherapy and photodynamic therapy in therapeutic bronchoscopy of lung cancers
Source: Eur Respir J 2006; 28: 200-218
Year: 2006
Is bronchoscopic photodynamic therapy a therapeutic option in lung cancer?
Source: Eur Respir J 2003; 22: 535-541
Year: 2003
Regional laser centre experience in bronchoscopic photodynamic therapy (PDT) in inoperable bronchopulmonary cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 595s
Year: 2002
Photodynamic therapy (PDT) for in-situ (CIS) and micro-invasive (MCI) lungs cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 492s
Year: 2004
Follow-up using fluorescence bronchoscopy for the patients with photodynamic therapy treated early lung cancer
Source: Annual Congress 2012 - The broad spectrum of diagnostic bronchoscopy
Year: 2012
Endobronchial brachytherapy in the treatment of malignant lung tumours
Source: Eur Respir J 2004; 24: 348-352
Year: 2004
Photodynamic therapy (PDT) for the prevention of lung cancer (The Pearl Trial).
Source: International Congress 2017 – Lung cancer: important scientific reports from endoscopists and thoracic surgeons
Year: 2017
Place of cryotherapy, brachytherapy and photodynamic therapy in therapeutic bronchoscopy of lung cancers
Source: Annual Congress 2011 - PG1 Interventional pulmonology
Year: 2011
Preoperative endobronchial photodynamic therapy improves surgical radicalism for locally advanced NSCLC
Source: Annual Congress 2012 - From the laser through the stent to the valve: the broad spectrum of interventional pneumology
Year: 2012
Photodynamic therapy for endoscopically early hilar lung cancer using diode laser and talaporfin sodium (laserphyrin)
Source: Annual Congress 2008 - Hot and cold techniques
Year: 2008
Endobronchial photodynamic therapy with chlorine E6 in III-IV stage central lung cancer
Source: Annual Congress 2011 - To stent or not to stent: interventional bronchoscopy
Year: 2011
Endoscopical laser treatment in combined therapy non small cell lung cancer (NSCLC)
Source: Eur Respir J 2002; 20: Suppl. 38, 463s
Year: 2002
Endobronchial intratumoral chemotherapy followed by surgery in early non-small-cell lung cancer with polypoid growth erroneously diagnosed as an advanced disease
Source: Eur Respir J 2006; 28: Suppl. 50, 610s
Year: 2006
Successful targeted therapy of advanced lung cancer
Source: Annual Congress 2013 –Grand Round on diagnostic and therapeutic challenges in thoracic oncology: an interactive session
Year: 2013
Long term assessment of photodynamic therapy for superficial bronchial cancer
Source: International Congress 2019 – New insights into pleural and bronchoscopic interventions
Year: 2019
Combined radiation therapy in treatment of tracheal cancers
Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours
Year: 2008
Endoscopic photodynamic therapy with e6 chlorine in advanced stage lung cancer: Preliminary results
Source: Annual Congress 2010 - Best supportive care and palliation for lung cancer patients
Year: 2010
A new treatment strategy for stage III lung cancer presenting with airway obstruction: neoadjuvant endobronchial intratumoral chemotherapy (EITC)
Source: Annual Congress 2009 - Biopsy techniques
Year: 2009
Treatment of limited disease-small cell lung cancer
Source: Eur Respir Mon; 2009: 44: 299–309
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept